Skip to main content

Ocugen, Inc.

OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001372299

In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Ocugen, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of OCGN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders9678−18
Shares48.7M33.0M−15.7M (−32.3%)
Value$26.5M$13.2M−$13.3M (−50.1%)

New holders (5)

Institutions that held Ocugen, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to OCGN in Q3 2023
InstitutionSharesValue% of portfolio
Zacks Investment Management55,481$22.2K0.00%
Bayesian Capital Management, LP47,700$19.1K0.00%
Mariner, LLC29,605$11.8K0.00%
EverSource Wealth Advisors, LLC2,444$9780.00%
GWM Advisors LLC317$1270.00%

Sold out (23)

Institutions that held Ocugen, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.